Minhua Deng

1.3k total citations
40 papers, 863 citations indexed

About

Minhua Deng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Minhua Deng has authored 40 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Minhua Deng's work include RNA modifications and cancer (9 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cancer-related molecular mechanisms research (6 papers). Minhua Deng is often cited by papers focused on RNA modifications and cancer (9 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cancer-related molecular mechanisms research (6 papers). Minhua Deng collaborates with scholars based in China, United States and Australia. Minhua Deng's co-authors include Dean O. Cliver, Martin Wiedmann, Pina M. Fratamico, Stephen Day, Rixin Chen, Dan Xie, Zhuowei Liu, Wensu Wei, Jin‐Ling Duan and Fangjian Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied and Environmental Microbiology and Chemical Engineering Journal.

In The Last Decade

Minhua Deng

39 papers receiving 839 citations

Peers

Minhua Deng
Minhua Deng
Citations per year, relative to Minhua Deng Minhua Deng (= 1×) peers Shihe Shao

Countries citing papers authored by Minhua Deng

Since Specialization
Citations

This map shows the geographic impact of Minhua Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minhua Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minhua Deng more than expected).

Fields of papers citing papers by Minhua Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minhua Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minhua Deng. The network helps show where Minhua Deng may publish in the future.

Co-authorship network of co-authors of Minhua Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Minhua Deng. A scholar is included among the top collaborators of Minhua Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minhua Deng. Minhua Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jiahao, Yongbo Peng, Sam Long, et al.. (2025). A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells. Biomaterials Science. 13(6). 1398–1413. 2 indexed citations
2.
Yang, Jun, Yaoyao Lu, Xu Cai, et al.. (2025). Comprehensive analysis of Enterobacteriaceae IncX plasmids reveals robust conjugation regulators PrfaH, H-NS, and conjugation-fitness tradeoff. Communications Biology. 8(1). 363–363. 1 indexed citations
3.
Chen, Rixin, Jianguo Wu, Minhua Deng, et al.. (2025). m6A-mediated circG3BP1 translocation to stress granules promotes nucleation and senescence-linked chemoresistance. Cell Reports. 44(10). 116375–116375.
4.
Chen, Rixin, Minhua Deng, Jiewei Chen, et al.. (2024). Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy. Signal Transduction and Targeted Therapy. 9(1). 80–80. 13 indexed citations
5.
Chen, Xin, Baohong Jiang, Yu‐Cheng Gu, et al.. (2024). SARS-CoV-2 nucleocapsid protein interaction with YBX1 displays oncolytic properties through PKM mRNA destabilization. Molecular Cancer. 23(1). 248–248. 3 indexed citations
6.
Deng, Minhua, Zhaohui Zhou, Jiawei Chen, et al.. (2024). Enhanced Oxidative Phosphorylation Driven by TACO1 Mitochondrial Translocation Promotes Stemness and Cisplatin Resistance in Bladder Cancer. Advanced Science. 12(5). e2408599–e2408599. 5 indexed citations
7.
Liu, Biao, JinRong Wang, Yongbo Peng, et al.. (2023). CD71/CD44 dual-aptamer-gemcitabine conjugate for tumor co-targeting treatment of bladder cancer. Chemical Engineering Journal. 464. 142597–142597. 5 indexed citations
8.
Hu, Xing, Hongliang Zeng, Yongbo Peng, et al.. (2023). Targeting PD‐L1 with DNA Aptamers and Conjugated with Gemcitabine as a Novel Therapeutic Strategy for Bladder Cancer Chemotherapy Combined with Immunotherapy. SHILAP Revista de lepidopterología. 3(12). 2300104–2300104. 1 indexed citations
9.
Chen, Jiawei, Lisi Zheng, Zikun Ma, et al.. (2023). NFYC-37 promotes tumor growth by activating the mevalonate pathway in bladder cancer. Cell Reports. 42(8). 112963–112963. 7 indexed citations
12.
Chen, Jiawei, Minhua Deng, Kang Ning, et al.. (2023). G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC‐I via PI3K/Akt Activation in Bladder Cancer. Advanced Science. 11(7). e2305922–e2305922. 14 indexed citations
13.
Kang, Ning, Yulu Peng, Yue Jiang, et al.. (2023). Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8+ T-cells highly infiltrated in males. Biology of Sex Differences. 14(1). 58–58. 16 indexed citations
14.
Peng, Yulu, Jun Wang, Zhen Li, et al.. (2022). Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis. Cancer Medicine. 11(19). 3674–3686. 3 indexed citations
15.
Duan, Jin‐Ling, Wei Chen, Juanjuan Xie, et al.. (2022). A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Molecular Cancer. 21(1). 93–93. 109 indexed citations
16.
Duan, Jin‐Ling, Run‐Cong Nie, Jiewei Chen, et al.. (2021). Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications. Journal of Hepatocellular Carcinoma. Volume 8. 493–505. 5 indexed citations
17.
Xiang, Liang, Qinghai Zeng, Jianye Liu, et al.. (2021). MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis. Science Bulletin. 66(17). 1773–1788. 31 indexed citations
18.
Peng, Yulu, Ning Kang, Zhiyong Li, et al.. (2021). Ureteral stents cannot decrease the incidence of ureteroileal anastomotic stricture and leakage: A systematic review and meta-analysis. International Journal of Surgery. 93. 106058–106058. 10 indexed citations
19.
Song, Qing, Yiyang Zhao, Yuqin Zeng, et al.. (2021). The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients. International Journal of COPD. Volume 16. 1401–1412. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026